1. bookAHEAD OF PRINT
Journal Details
License
Format
Journal
First Published
14 Sep 2008
Publication timeframe
6 times per year
Languages
English
access type Open Access

Current Trends in Prostate Cancer Etiology, Pathogenesis and Diagnostics

Published Online: 30 Aug 2021
Page range: -
Received: 12 Jan 2021
Accepted: 26 Apr 2021
Journal Details
License
Format
Journal
First Published
14 Sep 2008
Publication timeframe
6 times per year
Languages
English
Abstract

Prostate cancer (PCa) remains the second most commonly diagnosed cancer in men, with an estimated 1.1 million diagnoses worldwide in 2012, accounting for 15% of all cancers diagnosed. In many cases, successful treatment of prostate cancer is difficult due to late detection and rate of metastasis. Importantly, the tumours of many patients with prostate cancer become refractory to androgen therapy and progress to metastatic castration-resistant disease. An effective treatment course of prostate cancer patients requires predictive biomarkers in metastatic castration-resistant prostate cancer that support individual treatment. Different risk classification tools have been developed to distinguish patients with early PCa according to the prognosis, including the D’Amico classification system, the Cancer of the Prostate Risk Assessment score, and the National Comprehensive Cancer Network risk groups classification. Unfortunately, there is still no single, universal, cheap, non-invasive, early prostate cancer diagnostic tool, as serum prostate specific antigen (PSA) has not approved expectations and is not implemented in standardised prostate cancer screening. The aim of this review was to provide current state of art knowledge of prostate cancer screening, diagnosis, staging and future perspectives and directions.

Keywords

Aumüller, G. (1979). Prostate Gland and Seminal Vesicles. Springer-Verlag, Berlin-Heidelberg. 380 pp.Search in Google Scholar

Azmi, A. S., Bao, B., Sarkar, F. H. (2013). Exosomes in cancer development, metastasis, and drug resistance: A comprehensive review. Cancer Metastasis Rev.,32 (3–4), 623–642.Search in Google Scholar

Bishayee, K., Khuda-Bukhsh, A. R. (2013). 5-lipoxygenase antagonist therapy: A new approach towards targeted cancer chemotherapy. Acta Biochim. Biophys. Sin. (Shanghai),45 (9), 709–719.Search in Google Scholar

Brajtbord, J. S., Leapman, M. S., Cooperberg, M. R. (2017). The CAPRA score at 10 years: Contemporary perspectives and analysis of supporting studies. Eur. Urol., 71 (5), 705–709.Search in Google Scholar

Catalona, W. J., Partin, A. W., Sanda, M. G., Wei, J. T., Klee, G. G., Bangma, C. H., Slawin, K. M., Marks, L. S., Loeb, S., Broyles, D. L., et al. (2011). A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. J. Urol., 185 (5),1650–1655.Search in Google Scholar

D’Amico, A. V., Whittington, R., Malkowicz, S. B. (2000). Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J. Clin. Oncol.,18 (6), 1164–1172.Search in Google Scholar

Del Re, M., Biasco, E., Crucitta, S., Derosa, L., Rofi, E., Orlandini, C., Miccoli, M., Galli, L., Falcone, A., Jenster, G. W. (2017). The detection of androgen receptor splice variant 7 in plasma derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients. Eur. Urol., 71, 680–687.Search in Google Scholar

Filella, X., Fernández-Galan, E., Fernández Bonifacio, R., Foj L. (2018). Emerging biomarkers in the diagnosis of prostate cancer. Pharmgenomics Pers. Med.,11, 83–94.Search in Google Scholar

Ghosh, J., Myers, C. E. (1998). Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A., 95 (22), 13182–13187.Search in Google Scholar

Goldstein, A. S., Huang, J., Guo, C., Garraway, I. P., Witte, O. N. (2010). Identification of a cell of origin for human prostate cancer. Science.329 (5991), 568–571.Search in Google Scholar

Greene, E. R., Huang, S., Serhan, C. N., Panigrahy, D. (2011). Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat.,96 (1–4), 27–36.Search in Google Scholar

Helgesen, F., Holmberg, L., Johansson, J. E. (1996). Trends in prostate cancer survival in Sweden, 1960 through 1988, evidence of increasing diagnosis of non-lethal tumours. J. Natl. Cancer Inst.,88 (17), 1216–1221.Search in Google Scholar

Ingrosso, G., Detti, B., Scartoni, D., Lancia, A., Giacomelli, I., Baki, M., Carta, G., Livi, L., Santoni, R. (2018). Current therapeutic options in meta-static castration-resistant prostate cancer. Semin. Oncol.,45, 303–315.Search in Google Scholar

Jahn, J. L, Giovannucci, E. L., Stampfer, M. J. (2015). The high prevalence of undiagnosed prostate cancer at autopsy: Implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-era. Int. J. Cancer,137 (12), 2795–2802.Search in Google Scholar

Kharaziha, P., Chioureas, D., Rutishauser, D., Baltatzis, G., Lennartsson, L., Fonseca, P., Azimi, A., Hultenby, K., Zubarev, R., Ullen, A. (2015). Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Oncotarget,6, 21740–21754.Search in Google Scholar

Kim, S. J., Kim, S. I. (2011). Current treatment strategies for castration-resistant prostate cancer. Korean J. Urol.,52, 157–165.Search in Google Scholar

Kretschmer, A., Tilki, D. (2017). Biomarkers in prostate cancer: Current clinical utility and future perspectives. Crit. Rev. Oncol. Hematol.,120, 180–193.Search in Google Scholar

Leav, I., Plescia, J., Goel, H. L., Li, J., Jiang, Z., Cohen, R. J., Languino, L. R., Altieri, D. C. (2010). Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Amer. J. Pathol., 176 (1), 393–401.Search in Google Scholar

LSM.LV (2019). https://www.lsm.lv/raksts/zinas/latvija/visizplatitakais-veza-veids-viriesiem-prostatas-laundabigais-audzejs.a335221/ (accessed 10.08.2021) (in Latvian).Search in Google Scholar

Lu-Yao, G., Albertsen, P. C., Stamford, J. L. (2002). Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ,325 (7367), 740.Search in Google Scholar

Moore, K., Dalley, A. (1999). Clinically Oriented Anatomy. Lippincott Williams & Wilkins, Baltimore, Maryland. 1163 pp.Search in Google Scholar

Mottet, N., Cornford, P., van den Bergh, R. C. N., De Santis, M., Fanti, S., Gillessen, S., Grummet, J., Henry, A. M., Lam, T. B., Mason, M. D., van der Kwast, T. H., van der Poel, H. G., Rouviere, O., Schoots, I. G., Tilki, D., Wiegel, T. (2020). Oncology Guidelines, Prostate Cancer. https://uroweb.org/guideline/prostate-cancer/ (accessed 10.08.2021).Search in Google Scholar

Narizhneva, N. V., Tararova, N. D., Ryabokon, P., Shyshynova, I., Prokvolit, A., Komarov, P. G., Purmal, A. A., Gudkov, A. V., Gurova, K. V. (2009). Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer. Cell Cycle,8 (24), 4155–4167.Search in Google Scholar

Reedy, G. M., Cance, W. G., Kim, K., Lacasse, L., Phillips, T., Reicin, K. (2020). About Prostate Cancer. American Cancer Society.Search in Google Scholar

Rosenberg, J. E. (2005). Scientists discover anti-cancer mechanism that arrests early prostate cancer. Science Daily, 4 August. https://www.sciencedaily.com/releases/2005/08/050804074959.htm (accessed 10.08.2021).Search in Google Scholar

Schmelz, H. U., Sparwasser C., Weidner, W. (2006). Facharztwissen Urologie, Differenzierte Diagnostik und Therapie. Springer Medizin Verlag, Heidelberg. 736 S.Search in Google Scholar

Senapati, S., Rachagani, S., Chaudhary, K., Johansson, S. L., Singh, R. K., Batra, S. K. (2010). Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK–RhoA signaling pathway. Oncogene.29 (9), 1293–1302.Search in Google Scholar

Siegel, R. L., Miller, K. D., Jemal, A. (2019). Cancer statistics, 2019. CA Cancer J. Clin.69, 7–34.Search in Google Scholar

Soekmadji, C., Russell, P. J., Nelson, C. C. (2013). Exosomes in prostate cancer: Putting together the pieces of a puzzle. Cancers (Basel),5 (4), 1522–1544.Search in Google Scholar

Stieve, H. (1930). Männliche Genitalorgane. In: Handbuch der mikroskopischen Anatomie des Menschen. Vol. VII Part 2. Springer, Berlin.Search in Google Scholar

Strom, P., Kartasalo, K., Olsson, H., Solorzano, L., Delahunt, B., Berney, D. M., Bostwick, D. G., Evans, A. J., Grignon, D. J., Humphrey, P. A. et al. (2020). Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol., 21 (2), 222–232.Search in Google Scholar

Tarhan, F., Orcun, A., Kucukercan, I., Camursoy, N., Kuyumcuoglu, U. (2005). Effect of prostatic massage on serum complexed prostate-specific antigen levels. Urology,66,1234–1238.Search in Google Scholar

Thompson, I. M. (2006). PSA: A biomarker for disease. A biomarker for clinical trials. How useful is it? J. Nutr.,136, 2704S.Search in Google Scholar

van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., Nieuwland, R. (2012). Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev.,64 (3), 676–705.Search in Google Scholar

Van Leenders, G. J. L. H., van der Kwast, T. H., Grignon, D. J., Evans, A. J., Kristiansen, G., Kweldam, C. F., Litjens, G., McKenney, J. K., Melamed, J., Mottet, N., et al. (2020). The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Amer. J. Surg. Pathol., 44 (8), e87–e99.Search in Google Scholar

Watanabe, S. I., Miyata, Y., Kanda, S., Iwata, T., Hayashi, T., Kanetake, H., Sakai, H. (2009). Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy. J. Cancer Res. Clin. Oncol.,136 (5), 787–793.Search in Google Scholar

Yao, V., Berkman, C. E., Choi, J. K., O’Keefe, D. S., Bacich, D. J. (2010). Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid. Prostate,70 (3), 305–316.Search in Google Scholar

Zha, J., Huang, Y. F. (2009). TGF-beta/Smad in prostate cancer: An update. Zhonghua Nan Ke Xue (in Chinese),15 (9), 840–843.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo